See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Intrahepatic cholangiocarcinoma is a cancer that develops in the cells within the bile ducts; both inside and outside the liver. The terms cholangiocarinoma and bile duct cancer are often used to refer to the same condition. This condition occurs slightly more often in males than females and usually affects people who are between 50-70 years old. Signs and symptoms of intrahepatic cholangiocarcinoma include jaundice, abdominal pain, fever, weight loss, weakness and itching. Treatment options may include surgery to remove the bile duct and parts of the liver, chemotherapy and radiation.
Last updated: 4/1/2014
- Bile Duct Cancer (Cholangiocarcinoma). Johns Hopkins Medicine Liver Tumor Center. http://www.hopkinsmedicine.org/liver_tumor_center/conditions/bile_duct_cancer.html. Accessed 4/1/2014.
- The American Cancer Society provides information on Intrahepatic cholangiocarcinoma. Please click on the link to access this resource.
- Key C and Meisner ALW. Chapter 6: Cancers of the Liver and Biliary Tract. National Cancer Institute. SEER Survival Monograph.
- The National Cancer Institute provides the most current information on cancer for patients, health professionals, and the general public.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Intrahepatic cholangiocarcinoma. Click on the link to view a sample search on this topic.
- Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol. 2009 Sep 14;15(34):4240-62. [PDF]